Cargando…
Harnessing antitumor immunity: Employment of tumor recall antigens to optimize the inflammatory response to cancer
The advent of immunotherapy for cancer has contributed to the era of personalized medicine for cancer. The various immunotherapy-based treatments that have been explored thus far include monoclonal antibody therapy, tumor vaccines, immune checkpoint blockade and adoptive T cell transfer, among other...
Autores principales: | Silverio, Kimberly A., Patel, Shyam A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403274/ https://www.ncbi.nlm.nih.gov/pubmed/28454356 http://dx.doi.org/10.3892/ol.2017.5721 |
Ejemplares similares
-
Harnessing the immune response to target tumors
por: Manning, Luisa, et al.
Publicado: (2017) -
Randomized study of teriflunomide effects on immune responses to neoantigen and recall antigens
por: Bar-Or, Amit, et al.
Publicado: (2015) -
Harnessing the Effect of Adoptively Transferred Tumor-Reactive T Cells on Endogenous (Host-Derived) Antitumor Immunity
por: Nesbeth, Yolanda, et al.
Publicado: (2010) -
Harnessing the soil: reshaping the tumor microenvironment towards an antitumor immune state by low‐dose metformin
por: Lin, Yusheng, et al.
Publicado: (2021) -
How Informative is the Immune Response Against Surrogate Tumor Antigens to Assess Antitumor Immunity?
por: Janelle, Valérie, et al.
Publicado: (2014)